The role of radiotherapy in treating squamous cell carcinoma of the external auditory canal, especially in early stages of disease

• Published in: Radiotherapy and oncology 2000-08, Vol.56 (2), p.221-225
• Main Authors: Hashi, Noriko, Shirato, Hiroki, Omatsu, Tokuhiko, Kagei, Kenji, Nishioka, Takeshi, Hashimoto, Seiko, Aoyama, Hidefumi, Fukuda, Satoshi, Inuyama, Yukio, Miyasaka, Kazuo
• Format: Article
• Language: English
• Subjects: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell - pathology; Carcinoma, Squamous Cell - radiotherapy; Carcinoma, Squamous Cell - surgery; Dose Fractionation, Radiation; Ear Canal; Ear Neoplasms - pathology; Ear Neoplasms - radiotherapy; Ear Neoplasms - surgery; External auditory canal; Female; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy; Radiotherapy - methods; Radiotherapy Dosage; Retrospective Studies; Squamous cell carcinoma; Statistics, Nonparametric; Survival Rate; Treatment Outcome
• ISSN: 0167-8140; 1879-0887
• DOI: 10.1016/S0167-8140(00)00220-6

Purpose: Our intent was to investigate the role of radiotherapy in treating external auditory canal squamous cell carcinoma, especially in early stages of disease. Materials and methods: The treatment results for 20 patients treated between 1980 and 1998 were retrospectively analyzed. Radiotherapy was used as an initial treatment without surgery in eight patients and with surgery in 12 patients. The patients treated by radiotherapy alone received 65 Gy in 26 fractions over 6.5 weeks. The patients treated with radiotherapy perioperatively received 30–75 Gy in 12–30 fractions. The follow-up period for survivors including patients died of intercurrent disease ranged from 7 to 205 months (mean: 71 months). Results: The 5-year survival rate calculated by the Kaplan–Meier method for all patients was 59%. According to Stell classification (Laryncol. Otol. 99 (1985) 847), the 5-year survival rates for eight patients with T1 disease and eight with T2 disease were 100 and 38%, respectively. In the eight patients with T1 disease, disease control was 100%. Local control with hearing preservation was achieved in five patients with T1 disease by radiotherapy alone. No late complications related to radiotherapy were observed. Conclusions: A precise diagnosis of the disease in terms of whether or not it has invaded the bone is important in order to predict the treatment outcome. Radiotherapy with or without surgery is the treatment of choice for patients with T1-stage disease. Surgery with radiotherapy is recommended as standard care for tumors with bony invasion.